SHL Telemedicine - Disclosure of shareholdings

Tel Aviv / Zurich, 13 October 2017 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announced that it has received the following information related to the disclosure of shareholdings:

• Himalaya Asset Management Limited, via Himalaya (Cayman Island) TMT Fund, has sold shares and is now holding less than 3% of SHL's voting rights;
• Kun Shen, private investor based in Hong Kong, has acquired 2,559,250 SHLTN shares, representing 23.53% of voting rights in SHLTN.

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit our website at www.shl-telemedicine.com.

For further information, please contact:

Martin Meier-Pfister, IRF Communications, phone: +41 43 244 81 40, shl@irfcom.ch